Mary Ellen Sweeney

874 total citations
30 papers, 434 citations indexed

About

Mary Ellen Sweeney is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Mary Ellen Sweeney has authored 30 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Cardiology and Cardiovascular Medicine and 5 papers in Surgery. Recurrent topics in Mary Ellen Sweeney's work include Blood Pressure and Hypertension Studies (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Diabetes Treatment and Management (4 papers). Mary Ellen Sweeney is often cited by papers focused on Blood Pressure and Hypertension Studies (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Diabetes Treatment and Management (4 papers). Mary Ellen Sweeney collaborates with scholars based in United States, Canada and Australia. Mary Ellen Sweeney's co-authors include Gerald F. Fletcher, Barbara J. Fletcher, David C. Goff, Anona Armstrong, Barry R. Davis, Hertzel C. Gerstein, Marshall A. Corson, Richard H. Grimm, Marshall B. Elam and Joseph F. Largay and has published in prestigious journals such as Circulation, Diabetes Care and The American Journal of Medicine.

In The Last Decade

Mary Ellen Sweeney

29 papers receiving 410 citations

Peers

Mary Ellen Sweeney
Richard Kones United States
M. Dominique Ashen United States
Holly C. Schachner United States
D. Petzinna Germany
A G Olsson Sweden
Peter D. Montan United States
H BLACK United States
Susan Stephenson United States
Richard Kones United States
Mary Ellen Sweeney
Citations per year, relative to Mary Ellen Sweeney Mary Ellen Sweeney (= 1×) peers Richard Kones

Countries citing papers authored by Mary Ellen Sweeney

Since Specialization
Citations

This map shows the geographic impact of Mary Ellen Sweeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Ellen Sweeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Ellen Sweeney more than expected).

Fields of papers citing papers by Mary Ellen Sweeney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Ellen Sweeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Ellen Sweeney. The network helps show where Mary Ellen Sweeney may publish in the future.

Co-authorship network of co-authors of Mary Ellen Sweeney

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Ellen Sweeney. A scholar is included among the top collaborators of Mary Ellen Sweeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Ellen Sweeney. Mary Ellen Sweeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wright, Clinton B., Alexander P. Auchus, Alan J. Lerner, et al.. (2021). Effect of Intensive Versus Standard Blood Pressure Control on Stroke Subtypes. Hypertension. 77(4). 1391–1398. 3 indexed citations
2.
Roumie, Christianne L., Adriana M. Hung, Gregory B. Russell, et al.. (2019). Blood Pressure Control and the Association With Diabetes Mellitus Incidence. Hypertension. 75(2). 331–338. 22 indexed citations
3.
Ioachimescu, Octavian C., et al.. (2017). VAMONOS (Veterans Affairs’ Metabolism, Obstructed and Non-Obstructed Sleep) Study: Effects of CPAP Therapy on Glucose Metabolism in Patients with Obstructive Sleep Apnea. Journal of Clinical Sleep Medicine. 13(3). 455–466. 28 indexed citations
4.
Elam, Marshall B., Henry N. Ginsberg, Laura Lovato, et al.. (2016). Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes. JAMA Cardiology. 2(4). 370–370. 123 indexed citations
5.
Le, Ngoc‐Anh, et al.. (2013). Effect of ABT-335 (fenofibric acid) on meal-induced oxidative stress in patients with metabolic syndrome. Atherosclerosis. 231(2). 268–273. 1 indexed citations
6.
Drawz, Paul E., Sarah Baraniuk, Barry R. Davis, et al.. (2012). Cardiovascular risk assessment: Addition of CKD and race to the Framingham equation. American Heart Journal. 164(6). 925–931.e2. 15 indexed citations
7.
Barzilay, Joshua I., Barry R. Davis, Sara Pressel, et al.. (2012). Long-Term Effects of Incident Diabetes Mellitus on Cardiovascular Outcomes in People Treated for Hypertension. Circulation Cardiovascular Quality and Outcomes. 5(2). 153–162. 48 indexed citations
8.
Armstrong, Anona & Mary Ellen Sweeney. (2011). ENHANCING CORPORATE GOVERNANCE: DEMONSTRATING CORPORATE SOCIAL RESPONSIBILITY THROUGH SOCIAL REPORTING. Victoria University Research Repository (Victoria University). 2 indexed citations
9.
Mount, David L., Patricia Feeney, Anthony N. Fabricatore, et al.. (2009). Constructing common cohorts from trials with overlapping eligibility criteria: implications for comparing effect sizes between trials. Clinical Trials. 6(5). 416–429. 5 indexed citations
10.
Dunbar, Sandra B., et al.. (2007). Lifestyle physical activity in hypertensive rural elders: Association with self-efficacy related constructs. Circulation. 131.
11.
Sweeney, Mary Ellen, et al.. (2007). Ezetimibe: an update on the mechanism of action, pharmacokinetics and recent clinical trials. Expert Opinion on Drug Metabolism & Toxicology. 3(3). 441–450. 46 indexed citations
12.
O'Donovan, GM, et al.. (2001). Social Reporting and Australian Banks: Endorsement or Pretence to the Triple Bottom Line. eCite Digital Repository (University of Tasmania). 6 indexed citations
13.
Barzilay, Joshua I., Barry R. Davis, Jan Basile, et al.. (2001). Baseline Characteristics of the Diabetic Participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care. 24(4). 654–658. 26 indexed citations
14.
Sweeney, Mary Ellen, et al.. (2000). Debate: The potential role of estrogen in the prevention of heart disease in women after menopause. Trials. 1(3). 139–142. 3 indexed citations
15.
Sweeney, Mary Ellen. (1999). The Straight Story. 2 indexed citations
16.
Sweeney, Mary Ellen. (1995). How to Plan a Charter School.. Educational leadership. 52(1). 46–47. 2 indexed citations
17.
Fletcher, Gerald F., Mary Ellen Sweeney, & Barbara J. Fletcher. (1991). Blood magnesium and potassium alterations with maximal treadmill exercise testing: Effects of β-adrenergic blockade. American Heart Journal. 121(1). 105–110. 8 indexed citations
18.
Fletcher, Gerald F., Barbara J. Fletcher, & Mary Ellen Sweeney. (1990). Effects of exercise testing, training and beta blockade on serum potassium in normal subjects. The American Journal of Cardiology. 65(18). 1242–1245. 3 indexed citations
19.
Sweeney, Mary Ellen, Barbara J. Fletcher, & Gerald F. Fletcher. (1989). Exercise testing and training with β-adrenergic blockade: Role of the drug washout period in “unmasking” a training effect. American Heart Journal. 118(5). 941–946. 22 indexed citations
20.
Sweeney, Mary Ellen, et al.. (1985). Life Problems Experienced from Drinking: Factors Associated with Level of Problem Drinking among Youthful DWI Offenders.. Journal of alcohol and drug education. 30(3). 65–82. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026